FDA Adverse Event System Could Be Perfected At "Modest" Cost - Woodcock
Executive Summary
FDA needs a "modest" funding increase to perfect its adverse drug event reporting and surveillance systems, Center for Drug Evaluation & Research Director Janet Woodcock, MD, maintained during a Feb. 1 Senate Health Committee hearing on adverse drug events.
You may also be interested in...
Mandatory Medical Error Reporting To Be Established In Sen. Lieberman Bill
Health care providers would be required to report information on medical errors under legislation being developed by Sen. Lieberman (D-Conn.).
Mandatory Medical Error Reporting To Be Established In Sen. Lieberman Bill
Health care providers would be required to report information on medical errors under legislation being developed by Sen. Lieberman (D-Conn.).
PhRMA Medication Error Reduction Plan Slated For July Release
The Pharmaceutical Research & Manufacturers of America expects to have recommendations on reducing medication errors for member companies by early summer.